Skip to main content
VCbacked
Log inGet Started

Ability Pharmaceuticals

Barcelona, Spain

Ability Pharmaceuticals is a drug discovery and development company.

$7.7M raised
Mar 2024
Venture - Series Unknown
BiotechnologyHealth CarePharmaceutical

Top Investors

InvereadyEuropean Innovation CouncilCapital CellCTI Life Sciences FundSciClone Pharmaceuticals

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ability Pharmaceuticals

How much funding has Ability Pharmaceuticals raised?
Ability Pharmaceuticals has raised $7.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
Who are Ability Pharmaceuticals's investors?
Ability Pharmaceuticals's investors include Inveready, European Innovation Council, Capital Cell, CTI Life Sciences Fund, SciClone Pharmaceuticals.
Where is Ability Pharmaceuticals headquartered?
Ability Pharmaceuticals is headquartered in Barcelona, Spain.
What does Ability Pharmaceuticals do?
Ability Pharmaceuticals is a drug discovery and development company.
What stage is Ability Pharmaceuticals at?
Ability Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ability Pharmaceuticals — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/ability-pharmaceuticals. Accessed June 4, 2026.
APA
VCBacked. (2024). Ability Pharmaceuticals — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ability-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Ability Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/ability-pharmaceuticals |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong